Medical Devices
Home Healthcare Devices Market Size, 2024-2033
USD Billion
The figures are in the full report. Request a free sample ↗
Market overview
| Study Period | 2024 - 2033 |
|---|---|
| Historic Year | 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2033 |
| Market Size (Base Year) | USD 70.0 Billion |
| Market Size (Forecast Year) | USD 120.3 Billion |
| Growth Rate (CAGR) | 7.0 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Pages from the sample report. Figures are shown as XX here; the full report has them.
See the full sample: Request a free sample ↗
This report covers medical devices that patients use at home, excluding consumer smartwatches and fitness trackers. They are excluded because, counted at full value, they would make consumer electronics the largest part of a home healthcare market; only medical-grade wearables are included in that segment. The devices covered include monitoring devices such as glucose monitors, blood pressure monitors and pulse oximeters, therapeutic devices such as insulin pumps, sleep apnea and home oxygen therapy, nebulizers and hearing aids, and mobility aids such as wheelchairs, walkers and scooters.
Home healthcare devices let people manage long-term conditions, recover after surgery and live independently at home instead of in hospitals or care homes. Many are now connected, sending readings to doctors and care teams, and several, such as continuous glucose monitors and hearing aids, can now be bought over the counter in some countries. The market is measured at manufacturers' selling prices and includes the consumables sold with the devices, such as sensors, test strips and masks.
The number of older people and of people living with diabetes, sleep apnea, heart disease and hearing loss keeps rising. Health systems want to move care from hospitals into the home to reduce costs, and patients prefer to manage their conditions at home with devices that are smaller, easier to use and connected to their phones.
Continuous glucose monitors have spread from people who use insulin to wider groups, helped by over-the-counter versions and broader insurance coverage, and automated insulin pumps are growing quickly. Sleep apnea diagnosis at home and CPAP therapy keep growing, and hearing aids are becoming easier to buy and fit.
However, many devices depend on insurance and public reimbursement, which differs widely between countries and can be cut. Product recalls and regulatory action have disrupted supply in some categories, and price competition is strong in simple devices such as glucose meters, blood pressure monitors and mobility aids.
The global Home Healthcare Devices market is mainly classified based on device type, distribution channel and end user. On the basis of device type, the market is segmented into monitoring devices (blood glucose monitors, blood pressure monitors, pulse oximeters, medical-grade smartwatches and fitness trackers, sleep apnea monitors and others), therapeutic devices (insulin pumps, nebulizers, defibrillators, deep brain stimulation devices, compression therapy devices, sleep and respiratory therapy devices and others such as hearing aids and IV pumps) and home mobility assistance devices (walkers, wheelchairs, mobility scooters, transfer boards and others). Based on distribution channel, the market is categorized into retail pharmacies, e-commerce websites, home healthcare providers and others. By end user, the market is segmented into elderly care, chronic disease patients, post-operative care patients, patients with disabilities and others.
By device type, therapeutic devices account for the largest share, led by sleep and respiratory therapy, hearing aids and insulin pumps. Monitoring devices are the second-largest group and the fastest-growing, driven by continuous glucose monitors, while home mobility assistance devices are a large but slower-growing group.
By end user, chronic disease patients account for the largest share, as people with diabetes and sleep apnea use devices and consumables every day, followed by elderly care. By distribution channel, home healthcare providers and retail pharmacies lead, while e-commerce grows fastest.
North America is expected to hold the largest share of the global market, with the highest use of continuous glucose monitors, insulin pumps and CPAP devices, broad insurance coverage for home medical equipment and a large network of home medical equipment suppliers.
Europe is the second-largest market, with strong public reimbursement for diabetes devices, hearing aids and mobility aids in many countries. Asia-Pacific is expected to grow fastest, as China, India and Southeast Asia add diagnosis and treatment of diabetes and sleep apnea, and local makers supply affordable glucose meters, blood pressure monitors and mobility aids.
Latin America and the Middle East and Africa are smaller markets growing from a lower base.
Some of the major competitors in the global Home Healthcare Devices market include Abbott Laboratories, Dexcom, Inc., MiniMed Group, Inc. (Medtronic), Insulet Corporation, ResMed Inc., Koninklijke Philips N.V., Omron Corporation, F. Hoffmann-La Roche Ltd, Sonova Holding AG, Demant A/S, Invacare Corporation, and Sunrise Medical.
The Home Healthcare Devices industry is moderately concentrated: a few companies lead diabetes devices, sleep therapy and hearing aids, while blood pressure monitors, glucose meters and mobility aids have many regional makers. Companies compete on accuracy, ease of use, connectivity, consumables and reimbursement access, and are strengthening their position through new sensors and pumps, over-the-counter products, software for remote monitoring, separations and acquisitions.
Ans: The Home Healthcare Devices market, excluding consumer smartwatches, was valued at XX billion US$ in 2025 and is projected to reach YY billion US$ by 2033, at a CAGR of XX% during the forecast period.
Ans: Counted at full value, consumer smartwatches and fitness trackers would make consumer electronics the largest part of a home healthcare market, so only medical-grade wearables are included.
Ans: The main drivers are ageing populations, rising chronic disease such as diabetes and sleep apnea, and health systems moving care from hospitals into the home.
Ans: North America is expected to have the largest share of the Home Healthcare Devices market, while Asia-Pacific is expected to grow fastest.
Ans: Therapeutic devices, led by sleep and respiratory therapy, hearing aids and insulin pumps, are expected to dominate the market by device type.
Backed by 1 million+ hours of research experience across the industries we cover.
Domains covered
Countries covered
Committed to timely delivery
Projects delivered